Zanidatamab for treating HER2-positive advanced biliary tract cancer after 1 or more systemic treatments [ID6388]

  • In development
  • GID-TA11468
  • Expected publication date: 

NIHRIO BN: 30259-Zanidatamab-for-Biliary-Tract-Cancer-V2.0-OCT2023-NON-CONF.pdf (nihr.ac.uk)